The HIV Medicine Association is a community of health care professionals that advance a comprehensive and humane response to the HIV pandemic, informed by science and social justice.
A resource for frontline clinic staff to respond to COVID-19 vaccine questions with a special section on HIV.
This document on COVID-19 considerations for people with HIV (PWH) is intended as a resource for clinicians and public health officials. The information is based on evolving best practices developed during the coronavirus pandemic and the available published data on COVID-19.
An issue brief highlighting delivery system, staffing and administrative issues for clinics and clinicians to consider in preparing for the availability of long-acting antiretroviral treatment.
The HIV Medicine Association and the Infectious Diseases Society of America developed this document to respond to questions from HIV clinicians, and as a resource for HIV clinicians to respond to patient questions regarding COVID-19 vaccines.
Evidence-based guidelines for the management of persons infected with human immunodeficiency virus (HIV) were prepared by an expert panel of the HIV Medicine Association of the Infectious Diseases Society of America. These updated guidelines replace those published in 2009. The guidelines are intended for use by healthcare providers who care for HIV-infected patients. Since 2009, new antiretroviral drugs and classes have become available, and the prognosis of persons with HIV infection continues to improve.
